Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-20,700
Closed -$662K 847
2018
Q1
$662K Hold
20,700
0.01% 620
2017
Q4
$657K Buy
+20,700
New +$641K 0.01% 638
2016
Q4
Sell
-16,600
Closed -$398K 886
2016
Q3
$398K Hold
16,600
0.01% 627
2016
Q2
$446K Sell
16,600
-47,000
-74% -$1.29M 0.01% 677
2016
Q1
$1.73M Hold
63,600
0.05% 343
2015
Q4
$1.59M Buy
63,600
+9,300
+17% +$230K 0.04% 354
2015
Q3
$1.28M Buy
54,300
+40,000
+280% +$898K 0.03% 396
2015
Q2
$305K Buy
+14,300
New +$320K 0.01% 818
2014
Q2
Sell
-22,600
Closed -$394K 977
2014
Q1
$394K Hold
22,600
0.01% 716
2013
Q4
$415K Buy
+22,600
New +$422K 0.02% 659

Other funds holding G

Barings's G Position: Q2 2018 in Review

Barings sold out of Genpact (G) in Q2 2018, closing a stake of 20,700 shares — an estimated $662K sold.

Barings first reported a position in G in Q4 2013 and held it in 10 quarters. The position peaked at $1.73M in Q1 2016. 245 funds tracked by Wall St. Rank hold G as of Q2 2018.

  • Barings reported no remaining Genpact position as of Q2 2018 after selling out during the quarter.
  • Barings sold 20,700 Genpact shares in Q2 2018, an estimated $662K.
  • Barings first reported a position in Genpact in Q4 2013 and held it in 10 quarters.
  • Barings's Genpact position peaked at $1.73M in Q1 2016.
  • 245 funds tracked by Wall St. Rank held Genpact as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.